Multiple Sclerosis (spring) Flashcards

1
Q

define Multiple Sclerosis

A

Multiple sclerosis is a complex progressive disease of the central nervous system (brain & spinal cord), often characterised by a relapsing/remitting disease course

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Environmental factors for Multiple Sclerosis

A

Viral Exposure (Epstein Barr Virus)

Sunlight – Vit D

Tobacco exposure

Obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

genetic factors for Multiple Sclerosis

A

There is an increased risk linked to close family members developing the disease

  • 1st degree relatives (parent, children, sibling) have risk 2.5-5% developing MS
  • An identical twin with MS raises the risk to 20-25%

Genome wide association study identified further immune related genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

clinical presentation/ symptoms of multiple sclerosis

A

Uhthoff’s phenomenon - Symptoms take a huge turn for the worse upon an increase in body temperature (e.g. upon immersion in a hot bath)

Lhermitte’s sign - Electrical sensation running down the spine upon neck flexion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what does the diagnosis of multiple sclerosis involve?

A

MRI: to detect white matter abnormalities and spinal lesions

Diagnosis is a combination of time-course for clinical episodes, lesions detected by MRI and CSF markers

McDonald diagnostic criteria:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

causes of multiple sclerosis

A

The pathology of MS results from a combination of inflammation, demyelination and neurodegeneration

Inflammation in the brain and spinal cord

  • Inflammatory infiltrates mainly consist of lymphocytes and macrophages
  • The initial cause of inflammation in MS is not clear, and may be multifactorial

Loss of myelin sheaths (‘demyelination’).

Axonal damage and neuronal loss.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Consequences of multiple sclerosis

A

a) acute loss of function
b) repairable damage
c) chronic damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

fill in the table…

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

list treatments for multiple sclerosis

A

(Disease-modifying treatments and Symptomatic treatments)

steroids

Natalizumab

Fingolimod

Dimethyl fumarate

Alemtuzumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are steroids used for in MS and what dose?

A

Acute relapse episode

High dose corticosteroid

  • oral methylprednisolone, 500 mg daily, 3-5 days
  • i.v. methylprednisolone, 1g daily, 3-5 days

Once-daily oral immunomodulator

Teriflunomide inhibits dihydro-orotate dehydrogenase

This is required for de-novo pyrimidine synthesis pathway needed by rapidly dividing lymphocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is Natalizumab (Tysabri)

give its moa

what is it used for in MS?

dose?

A

Monoclonal antibody which inhibits leucocyte migration into CNS

Anti-inflammatory effects

Mechanism of action: binds to a4 subunit of a4b1 and a4b7 integrins, expressed on the surface of activated T-cells

Prevents binding of cells to receptors on the endothelium

Licensed for the treatment of adults with rapidly evolving severe relapsing-remitting multiple sclerosis

Linked to cases of Progressive multifocal leukoencephalopathy

Natalizumab is administered by intravenous infusion; the recommended dose is 300 mg every 28 days.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is Fingolimod (Gileyna)?

moa?

what does it do?

what is it used for in MS?

A

Sphingosine analogue

Sequesters lymphocytes in lymph nodes. Prevents them crossing BBB

Reduces rate of relapse

Fingolimod is recommended as an option for the treatment of highly active relapsing-remitting multiple sclerosis in adults, only if:

  • they have an unchanged or increased relapse rate or ongoing severe relapses compared with the previous year despite treatment with beta interferon, and
  • the manufacturer provides fingolimod with the discount agreed as part of the patient access scheme
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is Dimethyl fumarate?

moa?

A

Developed by Biogen as anti-MS therapy (as Tecfidera)

Thought to act as an anti-inflammatory agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

why do current NICE guidelines not recommend beta interferon and glatiramer acetate for MS?

A

too costly compared to the benefit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is Alemtuzumab?

what does it do in MS?

A

Anti-CD52 antibody

CD52: antigens expressed on B and T cells

Reduces inflammatory response in early MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the treatment options for Spasticity/spasms?

briefly give their moa

A

First line

  • baclofen (GABAb receptor agonist, inhibits spinal reflexes)
  • Gabapentin (calcium channel blocker) (now class C substance)

Second line

  • tizanidine (alpha2 agonist, muscle relaxant)
  • diazepam, clonazepam (benzodiazepines, GABAa agonists, act at level of the spinal cord to cause muscle relaxation)
  • dantrolene (ryanodine receptor agonist, muscle relaxant)
  • Intrathecal baclofen
  • Sativex
17
Q

what are the treatment options for Bladder and bowel symptoms (incontinence)?

A

(70-80% of MS patients)

Sativex recently licensed; Botulinum toxin shows promise.

Conventional medications for retention (alfuzosin), urgency/incontinence (trospium, flavoxate) etc.

18
Q

what are the treatment options for Pain?

A

80% of MS patients have pain

WHO pain ladder (NICE recommends specialist referral)

19
Q

what are the treatment options for Cognitive symptoms?

A

60% of MS patients have cognitive symptoms

Donepazil sometimes used

Cognitive training programmes

20
Q

treatment for Fatigue?

A

Modafinil

21
Q

treatment for Emotionalism?

A

tricyclic antidepressant or SSRI

22
Q

treatment for Depression?

A

Standard treatments

23
Q

treatment for depression or anxiety?

A

Standard treatments

24
Q

treatment for walking?

A

Fampridrine. K+ Channel blocker, approved in USA

Use not indicated in UK

25
Q

how are Cannabinoids related to MS?

A

Many MS patients self-medicate by smoking cannabis

Cannabinoids ameliorate many of the symptoms of MS

  • tremor and spasticity
  • pain associated with MS
  • Bladder function

Not recommended by NICE

26
Q

how is vitamin D releated to MS?

A

Lower incidence of MS in countries with more sunlight

Some suggestions that Vitamin D may help prevent MS, leading to the idea that it could be useful in treating MS

No clinical trial evidence to support use of Vitamin D, not recommended by NICE as a treatment for MS